AMREP CORP. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Amrep Corp. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and growth rate from Q1 2017 to Q2 2024.
  • Amrep Corp. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending July 31, 2024 was $40.9M, a 87.8% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $40.9M +$19.1M +87.8% Jul 31, 2024 10-Q 2024-09-13
Q1 2024 $30.2M +$10.2M +51.3% Apr 30, 2024 10-Q 2024-09-13
Q4 2023 $18M +$5.61M +45.2% Jan 31, 2024 10-Q 2024-03-08
Q3 2023 $16.7M +$3.83M +29.7% Oct 31, 2023 10-Q 2023-12-11
Q2 2023 $21.8M +$5.86M +36.8% Jul 31, 2023 10-Q 2024-09-13
Q1 2023 $20M +$4.27M +27.2% Apr 30, 2023 10-Q 2024-09-13
Q4 2022 $12.4M -$14.9M -54.6% Jan 31, 2023 10-Q 2024-03-08
Q3 2022 $12.9M -$17.4M -57.5% Oct 31, 2022 10-Q 2023-12-11
Q2 2022 $15.9M -$7.36M -31.6% Jul 31, 2022 10-Q 2023-09-13
Q1 2022 $15.7M -$9.08M -36.6% Apr 30, 2022 10-K 2024-07-23
Q4 2021 $27.3M +$11.9M +77.2% Jan 31, 2022 10-Q 2023-03-13
Q3 2021 $30.3M +$14.6M +93.3% Oct 31, 2021 10-Q 2022-12-12
Q2 2021 $23.3M +$6.21M +36.4% Jul 31, 2021 10-Q 2022-09-07
Q1 2021 $24.8M +$7.3M +41.7% Apr 30, 2021 10-K 2023-07-25
Q4 2020 $15.4M +$935K +6.46% Jan 31, 2021 10-Q 2022-03-10
Q3 2020 $15.7M +$2.8M +21.8% Oct 31, 2020 10-Q 2021-12-08
Q2 2020 $17.1M +$1.17M +7.37% Jul 31, 2020 10-Q 2021-09-14
Q1 2020 $17.5M +$3.27M +22.9% Apr 30, 2020 10-K 2022-07-21
Q4 2019 $14.5M +$238K +1.67% Jan 31, 2020 10-Q 2021-03-11
Q3 2019 $12.9M -$1.11M -7.9% Oct 31, 2019 10-Q 2020-12-08
Q2 2019 $15.9M +$796K +5.27% Jul 31, 2019 10-Q 2020-09-09
Q1 2019 $14.2M +$195K +1.39% Apr 30, 2019 10-K 2021-07-27
Q4 2018 $14.2M Jan 31, 2019 10-Q 2020-03-09
Q3 2018 $14M Oct 31, 2018 10-Q 2019-12-10
Q2 2018 $15.1M Jul 31, 2018 10-Q 2019-09-11
Q1 2018 $14M $0 0% Apr 30, 2018 10-K 2020-07-27
Q1 2017 $14M Apr 30, 2017 10-Q 2019-09-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.